D.E. Shaw & Co
GDRX icon

D.E. Shaw & Co’s GoodRx Holdings GDRX Stock Holding History

D.E. Shaw & Co’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-60,000
Closed -$1.16M – 5476
2022
Q1 		$1.16M Sell
60,000
-180,000
-75% -$4.13M ﹤0.01% 3782
2021
Q4 		$7.84M Sell
240,000
-93,100
-28% -$3.75M 0.01% 1910
2021
Q3 		$13.7M Buy
333,100
+90,000
+37% +$3.27M 0.01% 1281
2021
Q2 		$8.75M Buy
+243,100
New +$8.97M 0.01% 1604

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

D.E. Shaw & Co's GDRX Position: Q1 2026 in Review

D.E. Shaw & Co increased its GoodRx Holdings (GDRX) stake by 35% in Q1 2026, buying an estimated $189K and bringing the position to 312,128 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #3744.

D.E. Shaw & Co first reported a position in GDRX in Q2 2021 and has held it in 17 quarters since. The position peaked at $8.32M in Q1 2023. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • D.E. Shaw & Co held 312,128 shares of GoodRx Holdings worth $612K as of Q1 2026.
  • D.E. Shaw & Co bought 80,381 GoodRx Holdings shares in Q1 2026, an estimated $189K.
  • GoodRx Holdings made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3744 holding.
  • D.E. Shaw & Co first reported a position in GoodRx Holdings in Q2 2021 and has held it in 17 quarters since.
  • D.E. Shaw & Co's GoodRx Holdings position peaked at $8.32M in Q1 2023.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.